ALIBERTI, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 5.561
AS - Asia 4.917
EU - Europa 1.419
SA - Sud America 1.265
AF - Africa 104
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 13.279
Nazione #
US - Stati Uniti d'America 5.420
SG - Singapore 3.042
CN - Cina 1.116
BR - Brasile 1.105
IE - Irlanda 338
FI - Finlandia 274
IT - Italia 238
VN - Vietnam 213
HK - Hong Kong 195
DE - Germania 129
GB - Regno Unito 129
IN - India 75
CA - Canada 64
RU - Federazione Russa 62
AR - Argentina 61
BD - Bangladesh 52
MX - Messico 49
SE - Svezia 48
EC - Ecuador 41
PL - Polonia 36
TR - Turchia 34
JP - Giappone 32
ES - Italia 31
IQ - Iraq 29
ZA - Sudafrica 28
FR - Francia 26
CZ - Repubblica Ceca 25
ID - Indonesia 24
NL - Olanda 20
NG - Nigeria 18
UZ - Uzbekistan 15
MA - Marocco 14
CO - Colombia 13
EG - Egitto 13
SA - Arabia Saudita 13
KE - Kenya 12
UA - Ucraina 12
LT - Lituania 11
PE - Perù 10
PK - Pakistan 10
VE - Venezuela 10
AZ - Azerbaigian 9
IL - Israele 9
AE - Emirati Arabi Uniti 8
AU - Australia 8
DO - Repubblica Dominicana 8
PH - Filippine 8
UY - Uruguay 8
PY - Paraguay 7
TN - Tunisia 7
HN - Honduras 6
PT - Portogallo 6
CL - Cile 5
JO - Giordania 5
AO - Angola 4
BO - Bolivia 4
BY - Bielorussia 4
KG - Kirghizistan 4
AL - Albania 3
AT - Austria 3
BG - Bulgaria 3
DZ - Algeria 3
GR - Grecia 3
KR - Corea 3
MY - Malesia 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
OM - Oman 3
BH - Bahrain 2
CR - Costa Rica 2
DM - Dominica 2
HU - Ungheria 2
JM - Giamaica 2
LK - Sri Lanka 2
LV - Lettonia 2
NO - Norvegia 2
NP - Nepal 2
PA - Panama 2
QA - Qatar 2
RO - Romania 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BE - Belgio 1
CI - Costa d'Avorio 1
DK - Danimarca 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
HR - Croazia 1
KI - Kiribati 1
KN - Saint Kitts e Nevis 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
ML - Mali 1
MM - Myanmar 1
Totale 13.275
Città #
Dallas 1.312
Singapore 924
The Dalles 813
Ashburn 762
Shanghai 692
Boardman 462
New York 416
Dublin 337
Helsinki 273
Beijing 198
Hong Kong 188
Los Angeles 173
São Paulo 92
Seattle 81
Ho Chi Minh City 68
Santa Clara 66
Phoenix 52
London 51
Chandler 49
Naples 44
Hanoi 42
Moscow 42
Milan 40
Rio de Janeiro 35
Warsaw 34
Brooklyn 32
Montreal 27
Assago 26
Tokyo 25
Brasília 24
Chicago 23
Council Bluffs 23
Boston 22
Curitiba 22
Johannesburg 22
Atlanta 21
Belo Horizonte 20
Wilmington 20
Chennai 19
San Francisco 19
Benin City 18
Orem 18
Stockholm 18
Brno 17
Denver 16
Dhaka 15
Mexico City 15
Pune 15
Ankara 14
Munich 14
Campinas 13
Da Nang 13
Guarulhos 13
Guayaquil 13
Hangzhou 13
Tashkent 13
Quito 12
Salvador 12
Baghdad 11
Manchester 11
Nairobi 11
Haiphong 10
Lawrence 10
Porto Alegre 10
Praia Grande 10
Princeton 10
Ribeirão Preto 10
Rome 10
Shijiazhuang 10
Toronto 10
Baku 9
Houston 9
Amsterdam 8
Charlotte 8
Fortaleza 8
Maceió 8
Reston 8
Santo André 8
Thái Bình 8
Zhengzhou 8
Biên Hòa 7
Florence 7
Guangzhou 7
Itaquaquecetuba 7
Joinville 7
Juiz de Fora 7
Montes Claros 7
Ninh Bình 7
Poplar 7
San Jose 7
San Mateo 7
São Bernardo do Campo 7
Tel Aviv 7
Cairo 6
Cardiff 6
Cotia 6
Frankfurt am Main 6
Istanbul 6
Las Vegas 6
Montevideo 6
Totale 8.191
Nome #
100 years of respiratory medicine : Pneumonia 514
COVID-19 Vaccination Still Makes Sense: Insights on Pneumonia Risk and Hospitalization from a Large-Scale Study at an Academic Tertiary Center in Italy 374
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 104
Diagnosis and management of patients with alpha 1-antitrypsin deficiency: an Italian perspective 94
Acute myocardial infarction versus other cardiovascular events in community-acquired pneumonia 94
COVID-19 in Immunocompromised Patients: A Systematic Review 86
Community-acquired pneumonia 74
Mapping the human genetic architecture of COVID-19 73
A pathway to keep all lifelong learners up to date: The ERS continuing professional development programme 65
Quando ospedalizzare un paziente con polmonite acquisita in comunità 64
Clinical features associated with a doctor-diagnosis of bronchiectasis in the Severe Asthma Network in Italy (SANI) registry 64
A comprehensive analysis of the impact of pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis 63
A 13-year-old female with shortness of breath and pleuritic chest pain 60
Cardiovascular Complications in Community-Acquired Pneumonia 58
COVID-19 Network: the response of an Italian Reference Institute to research challenges about a new pandemia 57
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) 57
COVID-19 in lung transplant recipients: A case series from Milan, Italy 55
A DELAY IN REACHING TIME TO CLINICAL STABLITY FOR HOSPITALISED PATIENTS WITH CAP IS ASSOCIATED WITH FAILURE WITHIN 30 DAYS AFTER HOSPITAL DISCHARGE 55
A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation 54
An extensive bundle of tests is needed to detect treatable causes of bronchiectasis (Bx) 54
Treatable traits in interstitial lung diseases: a call to action 53
A Cluster Analysis of Bronchiectasis Patients Based on the Airway Immune Profile 53
A 61-year-old female with chronic cough and purulent sputum 53
A comprehensive approach to lung function in bronchiectasis 53
Acidemia does not affect outcomes of patients with acute cardiogenic pulmonary edema treated with continuous positive airway pressure 53
Cardiovascular side-effects of common antibiotics 53
A systematic review of the effect of delayed appropriate antibiotic treatment on the outcomes of patients with severe bacterial infections 53
Microbial Dysregulation of the Gut-Lung Axis in Bronchiectasis 52
A systematic review of pharmacotherapeutic clinical trial end-points for bronchiectasis in adults 51
Diagnosis and Initial Investigation of Bronchiectasis 51
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial 51
COVID-19 multidisciplinary high dependency unit: the Milan model 50
Post-COVID-19 sequelae 50
A real life evaluation of non invasive ventilation in acute cardiogenic pulmonary edema: a multicenter, perspective, observational study for the ACPE SIMEU study group 50
Comparison of different conditions for DNA extraction in sputum - a pilot study 49
Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia 49
Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients 49
A patient-tailored approach for corticosteroid treatment in COVID-19: still not there yet 49
Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases 49
Characterizing non-tuberculous mycobacteria infection in bronchiectasis 49
A New SERPINA-1 Missense Mutation Associated with Alpha-1 Antitrypsin Deficiency and Bronchiectasis 47
18-fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with non-tuberculous mycobacterial infectionsA case series on the use of Nuclear Medicine in NTM-PD 47
Early Phases of COVID-19 Are Characterized by a Reduction in Lymphocyte Populations and the Presence of Atypical Monocytes 46
Acute effects of positive end-expiratory pressure on left ventricle diastolic function in healthy subjects 46
Aspiration risks factors, microbiology and empiric antibiotics for patients hospitalized with community-acquired pneumonia 46
How to Identify Causes and Predisposing Factors in Bronchiectasis 45
Bacterial Patterns and Empiric Antibiotic Use in COPD Patients With Community-Acquired Pneumonia 44
Hepatic and pulmonary involvement in a patient with PR3-ANCA vasculitis following SARS-CoV-2 vaccination: a case report 44
A multicenter randomised control trial to evealuate CPAP versus conventional oxygen in patients with acute respiratory failure (ARF) due to CAP 44
What is the best technique to extract bacterial DNA from sputum? 44
Antibiotics for lung disease and cancer 44
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 44
O papel da neutropenia no prognóstico do doente oncológico com pneumonia adquirida na comunidade = The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia 43
A BEAT-PCD consensus statement: a core outcome set for pulmonary disease interventions in primary ciliary dyskinesia 43
Alpha1-Antitrypsin Inherited Variants in Patients With Bronchiectasis 43
Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia 43
Non-tuberculous mycobacteria pulmonary disease: an integrated approach beyond antibiotics 43
Dysregulation of the microbial ‘gut-lung’ axis in bronchiectasis 42
Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study 42
Genetic and Serum Screening for Alpha-1-Antitrypsin Deficiency in Adult Patients with Cystic Fibrosis: A Single-Center Experience 42
Efficacy of Pirfenidone and Nintedanib in Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis: A Systematic Review 41
Highlights on the appropriate use of fluoroquinolones in respiratory tract infections 41
A worldwide look into long COVID-19 management: an END-COVID survey 40
Investigating the Etiology of Bronchiectasis: You Do Not Find What You Do Not Look For 40
Prognostic parameters of in-hospital mortality in COVID-19 patients-An Italian experience 39
Antimicrobial peptides, disease severity and exacerbations in bronchiectasis 39
Respiratory failure in COVID-19: a patient's perspective and clinical cases 39
Complement activation in patients with COVID-19: a novel therapeutic target 39
Acute exacerbation of COPD: application of evidence-based guidelines 38
Pneumonia: how important are local epidemiology and smoking habits? 38
Site of care and multidisciplinary approach 38
Epidemiology and Resistance Profiles of Bacteria Isolated From Blood Samples in Septic Patients at Emergency Department Admission: A 6-Year Single Centre Retrospective Analysis From Northern Italy 38
Reassessing the Landscape of Viral Respiratory Infections After the COVID-19 Pandemic 38
Role of inhaled corticosteroids in reducing exacerbations in bronchiectasis patients with blood eosinophilia pooled post-hoc analysis of 2 randomized clinical trials 37
Treatment in exacerbations of the upper and lower airways 37
Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD 37
Mixed Community-acquired Lower Respiratory Tract Infections 36
Neutrophil elastase in bronchiectasis 36
Quinine treatment in severe Plasmodium falciparum malaria in children. A Holter monitoring 36
Diagnostic delay in bronchiectasis: an Italian perspective 36
Reazioni avverse polmonari 36
Chlamydia pneumoniae and Mycoplasma pneumoniae 35
Long-Term Outcomes in Severe Community-Acquired Pneumonia 35
Hospital-acquired pneumonia 35
The biology of pulmonary exacerbations in bronchiectasis 35
Positive end expiratory pressure in acute hypoxemic respiratory failure due to community acquired pneumonia: Do we need a personalized approach? 35
Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia 35
When and how ruling out cystic fibrosis in adult patients with bronchiectasis 34
Creatine combined with branched-chain amino acids supplement in speleological practice. A scientific controlled trial 34
Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia 34
Beyond pulmonary nontuberculous mycobacteria disease: do extra-pulmonary forms represent an emerging clinical and public health threat? 34
Clinical applications of azithromycin microspheres in respiratory tract infections 34
Prulifloxacin: a brief review of its potential in the treatment of acute exacerbation of chronic bronchitis 34
Management of hospitalised adults with coronavirus disease-19 (COVID-19): A European Respiratory Society living guideline 33
Blood eosinophils predict inhaled fluticasone response in bronchiectasis 33
How to recognize clinical stability in hospitalized patients with community-acquired pneumonia (CAP)? 33
What is important for people with NTM? An EMBARC-ELF patient survey 33
Acute exacerbations of COPD : application of evidence-based guidelines 33
Protease-Antiprotease Imbalance in Bronchiectasis 33
How to Process Sputum Samples and Extract Bacterial DNA for Microbiota Analysis 33
Totale 5.465
Categoria #
all - tutte 105.519
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.519


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202134 0 0 0 0 0 11 5 5 6 2 1 4
2021/202260 0 1 2 4 0 0 0 3 8 20 17 5
2022/2023594 25 8 19 9 16 5 55 14 43 65 321 14
2023/20243.339 221 156 792 191 171 605 220 92 39 141 294 417
2024/20254.287 118 19 40 87 100 514 236 233 936 1.113 454 437
2025/20265.414 1.768 856 1.264 954 431 141 0 0 0 0 0 0
Totale 13.738